F. Buonfiglioli

1.6k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

F. Buonfiglioli is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, F. Buonfiglioli has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 16 papers in Hepatology and 5 papers in Surgery. Recurrent topics in F. Buonfiglioli's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (11 papers) and Liver Disease and Transplantation (6 papers). F. Buonfiglioli is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (11 papers) and Liver Disease and Transplantation (6 papers). F. Buonfiglioli collaborates with scholars based in Italy. F. Buonfiglioli's co-authors include G. Mazzella, S. Brillanti, Pietro Andreoné, Fabio Conti, Francesco Giuseppe Foschi, Gabriella Verucchi, Paolo Caraceni, Marco Lenzi, Cristina Crespi and Luigi Bolondi and has published in prestigious journals such as Hepatology, Journal of Hepatology and Gastrointestinal Endoscopy.

In The Last Decade

F. Buonfiglioli

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

2016 653 citations Fabio Conti, F. Buonfiglioli et al. Journal of Hepatology profile →

Peers

F. Buonfiglioli

HEPAT

EPIDE

SURGE

ONCOL

PRM

O Inoue Japan

Claudio Puoti Italy

Óscar Núñez Spain

Shun‐Sheng Wu Taiwan

Xiangjun Jiang China

Elke Hennes Germany

J.‐P. Bronowicki France

Hee Sik Sun South Korea

Guido Colloredo Italy

Hung‐Da Tung Taiwan

O Inoue Japan

F. Buonfiglioli

901 ×1.0

HEPAT

909 ×1.1

EPIDE

109 ×0.8

SURGE

47 ×0.7

ONCOL

39 ×0.7

PRM

Citations per year, relative to F. Buonfiglioli F. Buonfiglioli (= 1×) peers O Inoue

Countries citing papers authored by F. Buonfiglioli

Since Specialization

Citations

This map shows the geographic impact of F. Buonfiglioli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Buonfiglioli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Buonfiglioli more than expected).

Fields of papers citing papers by F. Buonfiglioli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Buonfiglioli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Buonfiglioli. The network helps show where F. Buonfiglioli may publish in the future.

Co-authorship network of co-authors of F. Buonfiglioli

This figure shows the co-authorship network connecting the top 25 collaborators of F. Buonfiglioli. A scholar is included among the top collaborators of F. Buonfiglioli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Buonfiglioli. F. Buonfiglioli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gostoli, Sara, et al.. (2024). Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD). BMC Psychology. 12(1). 211–211. 1 indexed citations

Casadei‐Gardini, Andrea, Francesco Giuseppe Foschi, Fabio Conti, et al.. (2018). Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. Digestive and Liver Disease. 51(5). 681–688. 47 indexed citations

Ravaioli, Federico, Fabio Conti, S. Brillanti, et al.. (2018). Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals. Digestive and Liver Disease. 50(6). 573–579. 52 indexed citations

Conti, Fabio, Elisabetta Petracci, Giorgia Marisi, et al.. (2018). Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Digestive and Liver Disease. 50(1). 50–51. 2 indexed citations

Buonfiglioli, F. & S. Brillanti. (2018). Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum. Hepatoma Research. 4(2). 6–6. 3 indexed citations

Renzulli, Matteo, F. Buonfiglioli, Fabio Conti, et al.. (2017). Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis. European Radiology. 28(2). 506–513. 62 indexed citations

Conti, Fabio, F. Buonfiglioli, Alessandra Scuteri, et al.. (2016). Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Journal of Hepatology. 65(4). 727–733. 653 indexed citations breakdown →

Conti, Fabio, S. Brillanti, F. Buonfiglioli, et al.. (2016). Safety and efficacy of direct‐acting antivirals for the treatment of chronic hepatitis C in a real‐world population aged 65 years and older. Journal of Viral Hepatitis. 24(6). 454–463. 42 indexed citations

Lisotti, Andrea, Francesco Azzaroli, Alessandro Cucchetti, et al.. (2016). Relationship between indocyanine green retention test, decompensation and survival in patients with Child‐Pugh A cirrhosis and portal hypertension. Liver International. 36(9). 1313–1321. 28 indexed citations

10.

Renzulli, Matteo, F. Buonfiglioli, Stefano Brocchi, et al.. (2016). Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy.. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 64. 223–224. 1 indexed citations

11.

Cecinato, Paolo, Lorenzo Fuccio, Francesco Azzaroli, et al.. (2014). Extracorporeal shock wave lithotripsy for difficult common bile duct stones: a comparison between 2 different lithotripters in a large cohort of patients. Gastrointestinal Endoscopy. 81(2). 402–409. 12 indexed citations

12.

Lisotti, Andrea, Francesco Azzaroli, F. Buonfiglioli, et al.. (2013). Indocyanine Green Retention Test as a Noninvasive Marker of Portal Hypertension and Esophageal Varices in Compensated Liver Cirrhosis. Hepatology. 59(2). 643–650. 85 indexed citations

13.

Lodato, Francesca, Annalisa Berzigotti, Andrea Lisotti, et al.. (2012). Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience. Scandinavian Journal of Gastroenterology. 47(12). 1494–1500. 18 indexed citations

14.

Montagnani, Marco, Andrea Lisotti, Silvia Galli, et al.. (2011). High Dose Lamivudine in HBV-Related Cirrhotic Patients with Unsatisfactory Response After Adefovir Add-On. Digestive Diseases and Sciences. 57(2). 561–567.

15.

Sartini, Alessandro, et al.. (2011). Update on Crohn's disease: a polymorphic entity.. PubMed. 57(1). 89–96. 6 indexed citations

16.

Azzaroli, Francesco, Laura Turco, Andrea Lisotti, et al.. (2011). Alisporivir for the Treatment of Chronic HCV. Future Virology. 7(1). 9–18. 1 indexed citations

17.

Lodato, Francesca, Francesco Azzaroli, Laura Turco, et al.. (2010). Adverse effects of proton pump inhibitors. Best Practice & Research Clinical Gastroenterology. 24(2). 193–201. 66 indexed citations

18.

Baldini, Maria Teresa, Rita Golfieri, Francesco Azzaroli, et al.. (2009). Factors predicting mortality after TIPS for refractory ascites: A single center experience. Digestive and Liver Disease. 41(3). A42–A42. 1 indexed citations

19.

Golfieri, Rita, Francesco Azzaroli, Francesca Lodato, et al.. (2009). OUTCOMES AND SURVIVAL AFTER TIPS POSITIONING: A SINGLE CENTER EXPERIENCE. Digestive and Liver Disease. 41. S24–S25.

20.

Lisotti, Andrea, et al.. (2008). Lamivudine treatment for severe acute HBV hepatitis. International Journal of Medical Sciences. 5(6). 309–312. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact